CDC Notice of Intent to Sole Source for a Scanning Mobility Particle Sizer
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The Centers for Disease Control and Prevention (CDC) has issued a Notice of Intent to Sole Source for a Scanning Mobility Particle Sizer (SMPS). The CDC intends to award a contract to TSI Incorporated for this specialized laboratory equipment, which is crucial for inhalation research at their Morgantown, WV facility. Interested parties who believe they can meet the specific requirements must submit a capability statement by June 17, 2026.
Purpose
The objective is to procure a Scanning Mobility Particle Sizer (SMPS) to enable the Health Effects Laboratory Division, Physical Effects Research Branch, to accurately obtain particle size distributions for test dusts, powders, droplets, and collected aerosol samples within the 10 to 800 nm size range. This capability is vital for understanding inhalable particle sizes and their potential health effects.
Scope of Work
The vendor will be responsible for the fulfillment, packing, and shipping of the required equipment, which includes the Scanning Mobility Particle Sizer (Model 3938) and the Advanced Aerosol Neutralizer (Soft X-ray, Model 3088). The equipment will be delivered to NIOSH Morgantown, WV. CDC personnel will handle the setup of the instrument to research specifications.
Contract & Timeline
- Type: Notice of Intent to Sole Source (Simplified Acquisition Procedures)
- Intended Awardee: TSI Incorporated
- Period of Performance: Delivery by June 1, 2026; Operational period June 1, 2026 - May 31, 2027
- Set-Aside: None (Sole Source)
- Capability Statement Due: June 17, 2026, by 4:00 PM EST
- Published: June 10, 2026
Additional Notes
This is not a request for competitive quotations. The government has determined that TSI Incorporated is the only source available to meet the specific technical specifications for inhalation research. Any party believing they can perform this requirement should submit a capability statement for consideration. Information received will be used solely to determine if competitive procurement is feasible. Offerors must also comply with Section 508 and HHS Information and Communication Technology (ICT) accessibility standards, including submitting an Accessibility Conformance Report (ACR).